Irene Vinagre Selected Research

LDL Cholesterol

1/2023	Advanced lipoprotein profile identifies atherosclerosis better than conventional lipids in type 1 diabetes at high cardiovascular risk.
1/2014	Differences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study.
7/2012	Effect of improving glycemic control in patients with type 2 diabetes mellitus on low-density lipoprotein size, electronegative low-density lipoprotein and lipoprotein-associated phospholipase A2 distribution.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irene Vinagre Research Topics

Disease

17	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024 - 10/2010
12	Atherosclerosis 09/2023 - 08/2013
7	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2014
5	Pre-Eclampsia (Preeclampsia) 04/2022 - 10/2019
4	Hypertension (High Blood Pressure) 03/2023 - 10/2019
3	Hypoglycemia (Reactive Hypoglycemia) 03/2024 - 01/2017
3	Carotid Artery Diseases 03/2024 - 01/2021
2	Inflammation (Inflammations) 09/2023 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020 - 01/2015
2	Macular Edema 09/2020 - 01/2017
2	Weight Gain 10/2019 - 01/2017
2	Obesity 01/2015 - 02/2014
1	Lysinuric Protein Intolerance 10/2023
1	Fatty Liver 03/2023
1	Malnutrition (Nutritional Deficiencies) 03/2023
1	Insulin Resistance 03/2023
1	Cataract (Cataracts) 09/2020
1	Ischemia 01/2017
1	Retinal Detachment (Retinal Detachments) 01/2017
1	Diabetes Mellitus 10/2015
1	Perinatal Death 03/2015
1	Gestational Diabetes (Gestational Diabetes Mellitus) 03/2015
1	Overweight 01/2015
1	Addison Disease (Addison's Disease) 06/2014

Drug/Important Bio-Agent (IBA)

6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2023 - 10/2019
6	Glucose (Dextrose)FDA LinkGeneric 03/2023 - 01/2017
5	Biomarkers (Surrogate Marker)IBA 09/2023 - 02/2014
5	oxidized low density lipoproteinIBA 01/2023 - 07/2012
5	LipidsIBA 01/2023 - 04/2012
5	Insulin (Novolin)FDA Link 01/2020 - 05/2013
4	C-Reactive ProteinIBA 09/2023 - 01/2015
3	LDL CholesterolIBA 01/2023 - 07/2012
3	Lipoproteins (Lipoprotein)IBA 01/2023 - 08/2013
3	Glycoproteins (Glycoprotein)IBA 04/2022 - 01/2021
3	Blood Glucose (Blood Sugar)IBA 01/2022 - 03/2015
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 07/2012
3	HDL LipoproteinsIBA 01/2021 - 07/2012
2	CholesterolIBA 01/2023 - 01/2021
2	HDL CholesterolIBA 01/2023 - 01/2021
2	Fatty Acids (Saturated Fatty Acids)IBA 12/2021 - 01/2021
2	Retinaldehyde (Retinal)IBA 08/2021 - 01/2017
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 10/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017 - 07/2012
2	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 08/2013 - 07/2012
1	Amino Acids FDA Link 10/2023
1	SphingomyelinsIBA 03/2023
1	NitrogenIBA 01/2021
1	W 7 (W7)IBA 01/2021
1	VLDL LipoproteinsIBA 01/2021
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2021
1	N-acetyltryptophanamide (NATA)IBA 09/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2020
1	1- phenyl- 3- azabicyclo(3.1.0)hexane- 2,4- dioneIBA 03/2015
1	VLDL CholesterolIBA 01/2015
1	hydroxide ionIBA 01/2015
1	Vitamin D FDA LinkGeneric 01/2015
1	Interferon-alpha (Interferon Alfa)IBA 10/2010

Therapy/Procedure

6	Glycemic Control 03/2024 - 07/2012
5	Therapeutics 10/2019 - 10/2010
2	Injections 01/2022 - 01/2020
1	Mediterranean Diet 03/2024
1	Bariatric Surgery 03/2023
1	Self Care (Care, Self) 01/2022
1	Insulin Infusion Systems 06/2014